NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.32M | 3.66M | -7.22M | -10.12M | -10.66M |
| Total Depreciation and Amortization | 283.00K | 335.00K | 376.00K | 376.00K | 376.00K |
| Total Amortization of Deferred Charges | 194.00K | 485.00K | 874.00K | 1.44M | 1.96M |
| Total Other Non-Cash Items | 599.00K | 1.22M | 2.29M | 4.71M | 5.44M |
| Change in Net Operating Assets | -637.00K | 434.00K | -634.00K | -573.00K | 426.00K |
| Cash from Operations | 3.76M | 6.13M | -4.32M | -4.17M | -2.47M |
| Capital Expenditure | -2.00K | -2.00K | -4.00K | -7.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -2.00K | -4.00K | -7.00K | -6.00K |
| Total Debt Issued | 500.00K | 500.00K | 500.00K | 0.00 | 0.00 |
| Total Debt Repaid | -1.30M | -1.92M | -1.99M | -2.69M | -2.48M |
| Issuance of Common Stock | 3.49M | 3.72M | 3.11M | 3.67M | 791.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.99M | -1.91M | -115.00K | -2.00K | -2.00K |
| Cash from Financing | 707.00K | 389.00K | 1.50M | 974.00K | -1.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 126.00K | 126.00K | 126.00K | 590.00K | 313.00K |
| Net Change in Cash | 4.59M | 6.65M | -2.70M | -2.61M | -3.85M |